ArticlePharmaceuticals (Basel, Switzerland)2022

Exploring Mannosylpurines as Copper Chelators and Cholinesterase Inhibitors with Potential for Alzheimer's Disease.

Ignazio Schino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.